WO1996021154A1 - Electrogenerated chemiluminescence through enhanced particle luminescence - Google Patents
Electrogenerated chemiluminescence through enhanced particle luminescence Download PDFInfo
- Publication number
- WO1996021154A1 WO1996021154A1 PCT/US1996/000493 US9600493W WO9621154A1 WO 1996021154 A1 WO1996021154 A1 WO 1996021154A1 US 9600493 W US9600493 W US 9600493W WO 9621154 A1 WO9621154 A1 WO 9621154A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- label
- support
- metal
- luminescent
- solid phase
- Prior art date
Links
- 238000004020 luminiscence type Methods 0.000 title claims abstract description 10
- 238000001378 electrochemiluminescence detection Methods 0.000 title claims description 3
- 239000002245 particle Substances 0.000 title description 39
- 229910052751 metal Inorganic materials 0.000 claims abstract description 25
- 239000002184 metal Substances 0.000 claims abstract description 25
- 239000007790 solid phase Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 22
- 239000003446 ligand Substances 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 239000012491 analyte Substances 0.000 claims description 10
- 239000000427 antigen Substances 0.000 claims description 9
- -1 heterocyclic nitrogen-compound Chemical class 0.000 claims description 9
- 108020003215 DNA Probes Proteins 0.000 claims description 8
- 239000003298 DNA probe Substances 0.000 claims description 8
- 239000004793 Polystyrene Substances 0.000 claims description 8
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 8
- 102000036639 antigens Human genes 0.000 claims description 8
- 108091007433 antigens Proteins 0.000 claims description 8
- 239000011521 glass Substances 0.000 claims description 8
- 229920002223 polystyrene Polymers 0.000 claims description 8
- 229910052707 ruthenium Inorganic materials 0.000 claims description 8
- 239000000758 substrate Substances 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 150000001412 amines Chemical group 0.000 claims description 5
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical group CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 3
- 229910017464 nitrogen compound Inorganic materials 0.000 claims 1
- 150000002908 osmium compounds Chemical class 0.000 claims 1
- 238000003556 assay Methods 0.000 abstract description 8
- 230000003287 optical effect Effects 0.000 abstract description 5
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 239000011324 bead Substances 0.000 description 28
- 239000000243 solution Substances 0.000 description 12
- 238000000926 separation method Methods 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 5
- 230000005484 gravity Effects 0.000 description 5
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229910052762 osmium Inorganic materials 0.000 description 5
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000013522 chelant Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 230000027756 respiratory electron transport chain Effects 0.000 description 3
- 239000005361 soda-lime glass Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 3
- 229940033663 thimerosal Drugs 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 150000007945 N-acyl ureas Chemical class 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- RBFQJDQYXXHULB-UHFFFAOYSA-N arsane Chemical class [AsH3] RBFQJDQYXXHULB-UHFFFAOYSA-N 0.000 description 1
- WZSDNEJJUSYNSG-UHFFFAOYSA-N azocan-1-yl-(3,4,5-trimethoxyphenyl)methanone Chemical compound COC1=C(OC)C(OC)=CC(C(=O)N2CCCCCCC2)=C1 WZSDNEJJUSYNSG-UHFFFAOYSA-N 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 238000006056 electrooxidation reaction Methods 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002527 isonitriles Chemical class 0.000 description 1
- YADSGOSSYOOKMP-UHFFFAOYSA-N lead dioxide Inorganic materials O=[Pb]=O YADSGOSSYOOKMP-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 239000013528 metallic particle Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- GIDFDWJDIHKDMB-UHFFFAOYSA-N osmium ruthenium Chemical compound [Ru].[Os] GIDFDWJDIHKDMB-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- OUULRIDHGPHMNQ-UHFFFAOYSA-N stibane Chemical class [SbH3] OUULRIDHGPHMNQ-UHFFFAOYSA-N 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
Definitions
- the present invention relates to luminescent metal tagged supports and their use in assay, sequencing and separation
- the present invention relates to a solid phase support that provides reproducible surface presentation with enhanced light emission characteristics as a result of optical matching with a luminescent tag and used in immunoassays and DNA probe assays via electrogenerated chemiluminescent techniques.
- Diagnostic techniques such as immunoassays, DNA probe assays and, fluorescent and separation assays frequently involve a solid phase support or substrate.
- the supports often in particulate form, provide sites for
- the supports maybe be inorganic, such as siliceous based glasses, or they may be polymeric in composition, such as polystyrene.
- the solid phase support may contain metallic particles, such as iron oxide (Fe 2 O 3 ), that are coated with a material that provides appropriate sites for adhering the tagged component that aids in determining the analyte of interest.
- metallic particles such as iron oxide (Fe 2 O 3 )
- a material that provides appropriate sites for adhering the tagged component that aids in determining the analyte of interest.
- siliceous coatings will be applied. Instead of a coating, a particulate polymeric or siliceous material will incorporate Fe 2 O 3 to provide the magnetic properties. The magnetic content allows the support to be more easily
- the glass materials serve as a site for immobilizing an antibody, antigen, protein or probe etc.
- the magnetic properties allow the particles to be used in assays or reactors and be easily
- the porous material of Wong has a particle size on the order of 1 to about 200 ⁇ with a specific pore size.
- a variety of moiety components such as enzymes, antibodies, antigens, peptides, nucleotides, saccharides or cells are bonded to the support surface.
- saccharide or cell complements of the analyte of interest can be tagged with conventional tagging agents such as radioactive, colorimetric and/or luminescing agents.
- conventional tagging agents such as radioactive, colorimetric and/or luminescing agents.
- labels which can be made to luminesce through photochemical, chemical, or electro-chemical reaction schemes.
- electro-chemiluminescent methods of determining the presence of labelled materials are of interest for the insensitive, nonhazardous and
- ruthenium- and osmium-containing labels have been used for detecting and quantifying analytes of interest in liquid media (U.S. Patent Nos. 5,310,687; 5,238,808; and 5,221,605).
- electrogenerated chemiluminescent (ECL) measurements to detect solution phase DNA intercalated with ruthenium-containing labels have been described (Carter, M.T. et al. (1990) Bioconiugate Chem 2:257-263).
- ECL electrogenerated chemiluminescent
- the present invention overcomes the limitations and drawbacks of the prior art.
- the solid phase particles of glass or polystyrene of the present invention have a specified geometry to provide reproducible presentation of the particles to an electrode surface where they are concentrated.
- light transmitting characteristics of the particles are matched with the emission characteristics of an appropriate tag to enhance the transmission characteristics of the particle and therefore maximize the light transmission to the photodetector.
- the solid phase particles contain a covering or layer of a ruthenium- or osmium-containing chemiluminescent labeled ligand component on the surface thereof that will complex with an analyte of interest. The degree of coating is such that the particle surface is not completely saturated with the ligand-tag component. The light generated during electrogenerated chemiluminescent
- reaction is detected to determine the analyte of interest.
- An aspect of the present invention is to provide a complexible solid phase support formed from an optically suitable substrate with an exterior layer of a ruthenium or osmium containing label.
- the ruthenium or osmium label is reacted with a coreactant in the presence of an electrode to generate a detectable emission.
- the optically suitable substrate provides reproducible presentation of the substrate to an electrode surface to facilitate emission.
- a further aspect of the present invention is to provide a solid phase support that enhances luminescence in ECL environments via surface geometry and particle transparency.
- An object of the present invention is to detect an analyte of interest by providing a solid phase particle support containing a layer of bound luminescent metal label.
- the label complexes an analyte of interest and is
- Fig. 1 shows a tagged particle of the present invention in contact with an electrode.
- Fig. 2 shows a tagged particle that lacks surface geometry for reproducible presentation.
- Fig. 3 shows another embodiment of the present invention with a tagged particle providing reproducible presentation.
- Fig. 4 shows an analysis system for gravity separation.
- Fig. 5 shows a flow cell for use with magnetically separable particles according to the present.
- Fig. 6 shows the electrode
- the present invention provides enhanced particle luminescence by designing a particle with (1) geometry that provides reproducible presentation of the particle surface to an electrode; and (2) optical properties matched with the luminescent tag.
- optical properties is meant that the particle must be transparent to facilitate light emitted light during the electrochemiluminescent
- the preferred solid phase particulate support of the present invention includes soda lime glass or polystyrene beads, with or without magnetic particles.
- the particle geometry must present a reproducible surface to an electrode. Fibrous or particulate material that maximizes surface contact is preferred, including but not limited to particles that are spherical,
- Solid phase particles that are irregular in shape or are aggregates do not provide acceptable presentation and do not enhance the emission and luminescence of the reaction.
- uniformity in shape provides for improve concentration.
- a solid phase support particle 3 formed from polystyrene containing Fe 2 O 3 , or soda lime glass, can be collected on electrode 1 by a magnet (not shown) or by gravity. Particles containing Fe 3 O 4 are also contemplated.
- the polystyrene beads are
- the susceptibility - 10 -2 cgs units and surface area of about 3-5 m 2 /g.
- Uniform glass microspheres available from Duke Scientific Corporation are available in sizes of 1.5 to 40 ⁇ .
- the exterior surface of the bead contacts surface 2 of the electrode 1 at contact point 6.
- the particle 3 contains a plurality of ligand containing luminescent metal tags 4, although only one is shown for clarity. The size and surface
- an irregular shaped particle 7 has point contacts 8 that contact surface 2 of electrode 1.
- the point contacts do not necessarily provide the same degree of particle surface exposure as that of a spherical particle or bead.
- the irregularly shaped solid phase support particles precludes reproducible presentation of its surface to the electrode 1.
- Figure 3 is an alternative embodiment where the bead 9 is elliptical in shape and provides reproducible presentation of the surface, though to a lesser degree than a spherical bead.
- the size of the particulate support is also important because of the effective field distance of the electrode. It is believed that the electron transfer from the electrode to the support is most effective at a distance of up to about 100 ⁇ from the surface of the electrode.
- the mean diameter of the particles suitable for the present invention between about 0.25 to about 10 ⁇ , preferably about 1 to 4.5 ⁇ . Particle size is one of the many factors that contribute to the luminescent enhancing support of the present invention.
- the metal luminescent tag of the present invention is preferably a ruthenium or osmium containing compound and may have
- polydentate ligands or one or more monodentate ligands.
- polydentate ligands include aromatic and
- polydentate ligands include aromatic amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids
- heterocyclic ligands are nitrogen-containing, such as, for example, bipyridyl, bipyrazyl, terpyridyl, and phenanthrolyl. If the metal chelate has greater than one polydentate ligand, the polydentate ligands may be the same or different.
- Suitable polydentate ligands may be unsubstituted, or substituted by any of a large number of substituents known to the art.
- Suitable substituents include for example, alkyl, substituted alkyl, aryl, substituted aryl, aralkyl, substituted aralkyl, carboxylate, carboxaldehyde, carboxamide, cyano, amino, hydroxy, imino, hydroxycarbonyl, aminocarbonyl, amidine, guanidinium, ureide, sulfur-containing groups, phosphorous containing groups, and the carboxylate ester of N-hydroxysuccinimide.
- Suitable monodentate ligands include, for example, carbon monoxide, cyanides,
- a preferred metal luminescent compound is 4-methyl-4-N-succinimdyloxycarbonylpropyl-2,2-bipyridine Ru(II) hexafluorophosphate.
- the metal label is excited by exposing the solid phase supported metal label chelate to
- the potential at which the oxidation of the metal label will occur depends upon the exact structure of the metal label as well as factors such as the co-reactant utilized, the pH of the solution and the nature of the electrode used.
- suitable co-reactants which, when incubated with the solid phase supported metal label chelate in the presence of the electrochemical energy, will result in emission, include tripropylamine (TA), oxalate or other organic acid such as pyruvate, lactate, malonate, tartrate and citrate.
- TA tripropylamine
- oxalate organic acid
- This oxidation can also be performed chemically, with some strong oxidants such as PbO 2 or a Ce(IV) salt.
- electrochemiluminescent species may be measured by emitted electromagnetic radiation.
- the rate of energy inputted into the system can provide a measure of the luminescent species.
- the measurements can be made either as continuous, rate-based measurements, or as cumulative methods which accumulate the signal over a long period of time. An example of rate-based measurements would be by using
- photomultiplier tubes photomultiplier tubes, photodiodes or
- phototransistors to produce electric currents proportional in magnitude to the incident light intensity.
- Examples of cumulative methods are the integration of rate-based data, and the use of photographic film to provide cumulative data directly.
- FIGS. 4 and 5 exemplify systems that are suitable for electrogenerated
- an open vessel 21 contains an electrode 24 with a surface 25 upon which a metal tag containing luminescent support 23 will be collected or concentrated will rest.
- the bottom of the vessel may be sloped (not shown) to facilitate collection of the tagged supports 23 in solution 22 on the electrode surface 25. If supports 23 contain Fe 2 O 3 , a magnet 26 may be used.
- a solution containing a metal luminescent tagged support 37, or a sandwiched support 39 formed from the reaction of, for example, an antibody-antigen pair is fed through tube 32 of flow cell 31.
- the supports 37 and 39 are attracted to electrode 35 and maintained in position by magnet 34. Energy from electrode 35 across the surface 36 to the main support provides the energy for the reaction. If the device of figure 5 is used for gravity separation, the electrode 35 is located at bottom wall 38 (shown in broken lines).
- Dynal particles (4.5 ⁇ m) were coated with different amounts of labelled antibody from Example A.
- Example B electrochemiluminesence generated from the labelled beads (Example B) was done using a ORIGEN Analyzer and reagents (Igen,
- the analyzer first pumps the bead sample (150 ⁇ g/500 ⁇ l) to a flow cell containing a gold working electrode, counter electrode, and a Ag/AgCl reference electrode shown in Figure 6. The beads are then allowed to settle (by
- electrochemical excitation is performed.
- the settling time is varied depending on the density of the beads and the distance it must travel to reach the electrode - 370 ⁇ being the longest distance. Once the desired settling time is done, the excitation takes place with the subsequent generation of light.
- photomultiplier tube converts the light energy to electrical energy that is processed by a luminometer. Once the light has been collected and analyzed, the existing sample is washed away and the flow cell is cleaned and conditioned in preparation for the next sample of beads to be measured.
- Dynal particles (4.5 ⁇ m) (Table I, Example 1) were coated with labelled antibody prepared in Example A. 30 mg. were washed with PBS and subsequently added to 988 ⁇ l of PBS containing 0.005% thimerosal. 12 ⁇ l of 500 ⁇ g/ml labelled antibody (Example B) was then added to this particle mixture and allowed to rotate over 1 hour. The beads were then
- Example 1 The procedure described in Example 1 above was repeated using the particulate magnetic solid phase supports described for Examples 2-9 of Table I.
- Example 10 The procedure described in Example 10 above was repeated using the particulate magnetic solid phase supports described for Examples 2-9 of Table I.
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
An emission enhancing particulate support is disclosed where the optical properties of the support and the emissive characteristics of a metal luminescent tag are matched to provide enhanced luminescence in electrogenerated chemiluminescent assays.
Description
Title of the Invention
ELECTROGENERATED CHEMILUMINESCENCE THROUGH ENHANCED PARTICLE LUMINESCENCE Field Of Invention
The present invention relates to luminescent metal tagged supports and their use in assay, sequencing and separation
applications. In particular, the present invention relates to a solid phase support that provides reproducible surface presentation with enhanced light emission characteristics as a result of optical matching with a luminescent tag and used in immunoassays and DNA probe assays via electrogenerated chemiluminescent techniques.
Background Of Invention
Diagnostic techniques such as immunoassays, DNA probe assays and, fluorescent and separation assays frequently involve a solid phase support or substrate. The supports, often
in particulate form, provide sites for
antibodies, antigens and probes, that may or may not be tagged. The supports maybe be inorganic, such as siliceous based glasses, or they may be polymeric in composition, such as polystyrene.
The solid phase support may contain metallic particles, such as iron oxide (Fe2O3), that are coated with a material that provides appropriate sites for adhering the tagged component that aids in determining the analyte of interest. For example, polymeric or
siliceous coatings will be applied. Instead of a coating, a particulate polymeric or siliceous material will incorporate Fe2O3 to provide the magnetic properties. The magnetic content allows the support to be more easily
concentrated and /or separated. Porous bodies of magnetic glass or crystals containing
magnetic crystals are also known. The glass materials serve as a site for immobilizing an antibody, antigen, protein or probe etc. The magnetic properties allow the particles to be used in assays or reactors and be easily
separated therein. See for example U.S. Patent Nos. 3,042,543 to Schuele, U.S. Patent No.
4,233,169 to Beall et al., 4,631,211 to
Houghten, 4,812,512 to Buendia et al., 5,037,882 to Steel, 5,141,813 to Nelson and 5,128,204 to Charmot.
In PCT Application WO 93/10162 to Wong, magnetic porous inorganic supports are prepared for use in chromatography,
immunoassays, synthesis, separation and
purification techniques. The porous material of Wong has a particle size on the order of 1 to about 200 μ with a specific pore size. A variety of moiety components such as enzymes, antibodies, antigens, peptides, nucleotides, saccharides or cells are bonded to the support surface.
it is also known that enzyme, antibody, antigen, peptide, nucleotides,
saccharide or cell complements of the analyte of interest can be tagged with conventional tagging agents such as radioactive, colorimetric and/or luminescing agents. Of particular interest are labels which can be made to luminesce through photochemical, chemical, or electro-chemical reaction schemes. In particular, electro-chemiluminescent methods of determining the presence of labelled materials are of interest for the insensitive, nonhazardous and
inexpensive properties of the technique.
Present electrochemiluminescent methods use organic compounds and metal
chelates. For example, Leland et al. in J. of Electrochemical Society, Vol. 137, No. 10, October 1990 report an ECL reaction between amines, such as, tripropylamine and Ru(bpy)3 2+ (bpy 2,2'bipyridine). It is proposed that upon electrochemical oxidation of both a luminophore and coreactant amine a strong emission is observed. Use of Os(bpy)3 2+ is also taught by Leland et al. Electrochemiluminescent
ruthenium- and osmium-containing labels have been used for detecting and quantifying analytes of interest in liquid media (U.S. Patent Nos. 5,310,687; 5,238,808; and 5,221,605). In addition, electrogenerated chemiluminescent (ECL) measurements to detect solution phase DNA intercalated with ruthenium-containing labels have been described (Carter, M.T. et al. (1990) Bioconiugate Chem 2:257-263). However,
detection of solution phase analytes is
diffusion controlled and has several drawbacks relative to detection of analytes on solid surfaces. Some of the advantages for solid phase techniques as opposed to solution
techniques are: (1) greater sensitivity
(detection of monolayer quantities); and (2)
easier support separation. These luminescent systems are of increasing importance in
diagnostics.
In U.S. Pat. No. 4,372,745, chemiluminescent labels are used in
immunochemical applications where the labels are excited into a luminescent state by reaction of the label with H2O2 and an oxalate. However, though the system offers versatility, it lacks selectivity or specificity because typical biological fluids containing the analyte of interest also contain a large number of
potentially luminescent substances that can cause high background levels of luminescence.
Thus, a need exists for a solid phase system and method that (1) avoids the drawbacks of a diffusion controlled system; (2) is
selective; (3) provides a light transmission enhancing support; and (4) provides for
reproducible contact with an electrode. The present invention overcomes the limitations and drawbacks of the prior art.
Summary of Invention
The present invention enhances the emission characteristics of solid phase
particles that are used in immuno and DNA probe
assays and other applications. The solid phase particles of glass or polystyrene of the present invention have a specified geometry to provide reproducible presentation of the particles to an electrode surface where they are concentrated. In addition, light transmitting characteristics of the particles are matched with the emission characteristics of an appropriate tag to enhance the transmission characteristics of the particle and therefore maximize the light transmission to the photodetector. The solid phase particles contain a covering or layer of a ruthenium- or osmium-containing chemiluminescent labeled ligand component on the surface thereof that will complex with an analyte of interest. The degree of coating is such that the particle surface is not completely saturated with the ligand-tag component. The light generated during electrogenerated chemiluminescent
reaction is detected to determine the analyte of interest.
Thus, an object of the present
invention is improve light emission
characteristics of solid phase-particulate supports for use in immuno and DNA probe assays.
An aspect of the present invention is to provide a complexible solid phase support
formed from an optically suitable substrate with an exterior layer of a ruthenium or osmium containing label. The ruthenium or osmium label is reacted with a coreactant in the presence of an electrode to generate a detectable emission. The optically suitable substrate provides reproducible presentation of the substrate to an electrode surface to facilitate emission.
A further aspect of the present invention is to provide a solid phase support that enhances luminescence in ECL environments via surface geometry and particle transparency.
An object of the present invention is to detect an analyte of interest by providing a solid phase particle support containing a layer of bound luminescent metal label. The label complexes an analyte of interest and is
attracted to or collected on an electrode and thereafter reacted with a coreactant via
electron transfer from the electrode to emit a detectable emission.
These and other objects will become more apparent from the following detailed description and drawings.
Brief Description Of The Drawings
Fig. 1 shows a tagged particle of the present invention in contact with an electrode. Fig. 2 shows a tagged particle that lacks surface geometry for reproducible presentation. Fig. 3 shows another embodiment of the present invention with a tagged particle providing reproducible presentation. Fig. 4 shows an analysis system for gravity separation.
Fig. 5 shows a flow cell for use with magnetically separable particles according to the present.
Fig. 6 shows the electrode
arrangement for ECL
analysis.
Detailed Description Of Invention
The present invention provides enhanced particle luminescence by designing a particle with (1) geometry that provides reproducible presentation of the particle surface to an electrode; and (2) optical properties matched with the luminescent tag. By optical properties is meant that the particle must be transparent to facilitate light emitted light during the electrochemiluminescent
reaction and be matched to the emissive
characteristics of the tag. It was unexpected that matching the optical properties of the solid phase support with the emissive
characteristics of the luminescent tag would provide the results obtained.
The preferred solid phase particulate support of the present invention includes soda lime glass or polystyrene beads, with or without magnetic particles. The particle geometry must present a reproducible surface to an electrode. Fibrous or particulate material that maximizes surface contact is preferred, including but not limited to particles that are spherical,
ellipsoid, oval in shape can also be used.
Solid phase particles that are irregular in shape or are aggregates do not provide
acceptable presentation and do not enhance the emission and luminescence of the reaction.
Also, uniformity in shape provides for improve concentration.
With reference to figure 1, a solid phase support particle 3 formed from polystyrene containing Fe2O3, or soda lime glass, can be collected on electrode 1 by a magnet (not shown) or by gravity. Particles containing Fe3O4 are also contemplated. The polystyrene beads are
Dynabeads™ M-450, available from Dynal A.S., and are uncoated, uniform and magnetic with -OH resistance. They have a mean diameter of 4.5 μm (C.V. max 5%); s.g. = 1.5; magnetic
susceptibility - 10-2 cgs units; and surface area of about 3-5 m2/g. Uniform glass microspheres, available from Duke Scientific Corporation are available in sizes of 1.5 to 40μ. The exterior surface of the bead contacts surface 2 of the electrode 1 at contact point 6. The particle 3 contains a plurality of ligand containing luminescent metal tags 4, although only one is shown for clarity. The size and surface
geometry of particle 3 permits electrons from electrode 2 to flow through the bead to provide the necessary electron transfer, i.e.,
activation for the reaction.
In figure 2, an irregular shaped particle 7 has point contacts 8 that contact surface 2 of electrode 1. The point contacts do not necessarily provide the same degree of particle surface exposure as that of a spherical particle or bead. In addition, the irregularly shaped solid phase support particles precludes reproducible presentation of its surface to the electrode 1.
Figure 3 is an alternative embodiment where the bead 9 is elliptical in shape and provides reproducible presentation of the surface, though to a lesser degree than a spherical bead.
The size of the particulate support is also important because of the effective field distance of the electrode. It is believed that the electron transfer from the electrode to the support is most effective at a distance of up to about 100Å from the surface of the electrode.
The mean diameter of the particles suitable for the present invention between about 0.25 to about 10μ, preferably about 1 to 4.5μ. Particle size is one of the many factors that contribute to the luminescent enhancing support of the present invention.
The metal luminescent tag of the present invention is preferably a ruthenium or osmium containing compound and may have
polydentate ligands or one or more monodentate ligands. A wide variety of these ligands are known to the art. Polydentate ligands of either ruthenium or osmium include aromatic and
aliphatic ligands. Suitable aromatic
polydentate ligands include aromatic
heterocyclic ligands. Preferred aromatic heterocyclic ligands are nitrogen-containing, such as, for example, bipyridyl, bipyrazyl, terpyridyl, and phenanthrolyl. If the metal chelate has greater than one polydentate ligand, the polydentate ligands may be the same or different.
Suitable polydentate ligands may be unsubstituted, or substituted by any of a large number of substituents known to the art.
Suitable substituents include for example, alkyl, substituted alkyl, aryl, substituted aryl, aralkyl, substituted aralkyl, carboxylate, carboxaldehyde, carboxamide, cyano, amino, hydroxy, imino, hydroxycarbonyl, aminocarbonyl, amidine, guanidinium, ureide, sulfur-containing groups, phosphorous containing groups, and the carboxylate ester of N-hydroxysuccinimide.
Suitable monodentate ligands include, for example, carbon monoxide, cyanides,
isocyanides, halides, and aliphatic, aromatic and heterocyclic phosphines, amines, stibines, and arsines. A more complete list of the ligands, e.g., monodentate and polydentate ligands, and methods of preparing that can be used in the present invention are set forth in U.S. Patent Nos. 5,310,687, 5,238,808 and
5,221,605, the subject matter of which are incorporated herein by reference. A preferred metal luminescent compound is 4-methyl-4-N-succinimdyloxycarbonylpropyl-2,2-bipyridine Ru(II) hexafluorophosphate.
According to the present invention, the metal label is excited by exposing the solid phase supported metal label chelate to
electrochemical energy. The potential at which the oxidation of the metal label will occur depends upon the exact structure of the metal label as well as factors such as the co-reactant utilized, the pH of the solution and the nature of the electrode used. Examples of suitable co-reactants which, when incubated with the solid phase supported metal label chelate in the presence of the electrochemical energy, will result in emission, include tripropylamine (TA),
oxalate or other organic acid such as pyruvate, lactate, malonate, tartrate and citrate. This oxidation can also be performed chemically, with some strong oxidants such as PbO2 or a Ce(IV) salt.
Those of ordinary skill in the art recognize how to determine the optimal potential and emission wave length of an
electrochemiluminescent system. The
electrochemiluminescent species may be measured by emitted electromagnetic radiation. For example, the rate of energy inputted into the system can provide a measure of the luminescent species. The measurements can be made either as continuous, rate-based measurements, or as cumulative methods which accumulate the signal over a long period of time. An example of rate-based measurements would be by using
photomultiplier tubes, photodiodes or
phototransistors to produce electric currents proportional in magnitude to the incident light intensity. Examples of cumulative methods are the integration of rate-based data, and the use of photographic film to provide cumulative data directly.
All of these luminescence-based methods entail repeated luminescence by the
ruthenium-containing compound. The repetitive nature of the detectable event distinguishes these labels from radioactive isotopes or bound chemiluminescent molecules such as luminol. The latter labels produce a detectable event only once per molecule (or atom) of label, thereby limiting their detectability.
Figures 4 and 5 exemplify systems that are suitable for electrogenerated
chemiluminescence. In figure 4, gravity
separation is relied upon. In the figure, an open vessel 21 contains an electrode 24 with a surface 25 upon which a metal tag containing luminescent support 23 will be collected or concentrated will rest. The bottom of the vessel may be sloped (not shown) to facilitate collection of the tagged supports 23 in solution 22 on the electrode surface 25. If supports 23 contain Fe2O3, a magnet 26 may be used.
In figure 5, a solution containing a metal luminescent tagged support 37, or a sandwiched support 39 formed from the reaction of, for example, an antibody-antigen pair, is fed through tube 32 of flow cell 31. The supports 37 and 39 are attracted to electrode 35 and maintained in position by magnet 34. Energy from electrode 35 across the surface 36 to the
main support provides the energy for the reaction. If the device of figure 5 is used for gravity separation, the electrode 35 is located at bottom wall 38 (shown in broken lines).
The following examples illustrate various aspects of the invention but are in no way intended to limit the scope of the
invention.
Example A
45 μl of a DMSO solution of 4-methyl- 4-N-succinimdyloxy-carbonylpropyl-2,2-bipyridine Ru(II) hexafluorophosphate (0.5 mg in 62.5 μl) was added to a stirred solution of murine IgG in aqueous Physiologic Buffered Saline (182 μl of 1 mg/ml IgG to 318 μl PBS). The solution was incubated on a rotator at room temperature for approximately 30 minutes. The coupling reaction was stopped by adding 25 μl of a 2M glycine solution. The metal labelled antibody was separated from unreacted antibody and
derivitized ruthenium using a Sephadex G-25 column. The labelled antibody product was analyzed spectrophotometrically.
Example B
To determine a degree of coating that does not saturate the beads surface area, Dynal particles (4.5 μm) were coated with different amounts of labelled antibody from Example A. Four 30 mg bead aliquots were washed with PBS and subsequently mixed in four separate tubes containing 530, 880, 952, and 988 μl of PBS containing 0.005% thimerosal. To their
respective bead mixtures, 470, 120, 48, and 12 μl of 500 μg/ml labelled antibody (Example A) was then added, and each mixture allowed to rotate over 1 hour. The beads were then
separated from their solutions using a magnet. The supernatant was removed and saved for electrochemiluminescence analysis. 1 ml of PBS containing 3% BSA was then added to the beads which were allowed to rotate for 1 hour to block any remaining unoccupied areas on the particles. This washing and separation process was repeated once more, and afterwards the beads were stored in PBS with 3% BSA.
Example C
Analysis of the
electrochemiluminesence generated from the
labelled beads (Example B) was done using a ORIGEN Analyzer and reagents (Igen,
Incorporated) or could be performed in the systems described in figure 4 and 5 above. The analyzer first pumps the bead sample (150 μg/500μl) to a flow cell containing a gold working electrode, counter electrode, and a Ag/AgCl reference electrode shown in Figure 6. The beads are then allowed to settle (by
gravity) to the electrode surface where
electrochemical excitation is performed. The settling time is varied depending on the density of the beads and the distance it must travel to reach the electrode - 370 μ being the longest distance. Once the desired settling time is done, the excitation takes place with the subsequent generation of light. A
photomultiplier tube converts the light energy to electrical energy that is processed by a luminometer. Once the light has been collected and analyzed, the existing sample is washed away and the flow cell is cleaned and conditioned in preparation for the next sample of beads to be measured.
Example 1
Dynal particles (4.5 μm) (Table I, Example 1) were coated with labelled antibody prepared in Example A. 30 mg. were washed with PBS and subsequently added to 988 μl of PBS containing 0.005% thimerosal. 12 μl of 500 μg/ml labelled antibody (Example B) was then added to this particle mixture and allowed to rotate over 1 hour. The beads were then
separated from the solution using a magnet. The supernatant was removed and saved for
electrochemiluminescence analysis. 1 ml of PBS containing 3% BSA was then added to the beads which were allowed to rotate for 1 hour to block any remaining unoccupied areas on the particles. The beads were separated again. This washing and separation process was repeated once more, and afterwards the beads were stored in PBS with 3% BSA.
The results of an ECL analysis are set for in Table I.
Examples 2-9
The procedure described in Example 1 above was repeated using the particulate
magnetic solid phase supports described for Examples 2-9 of Table I.
Example 10
Glass beads (2 μm) were coated with labelled antibody prepared in Example A. 30 mg of the beads were washed with PBS and
subsequently added to 988 μl of PBS containing 0.005% thimerosal. 12 μl of 500 μg/ml labelled antibody (prepared in Example B) was then added to this bead mixture and allowed to rotate over 1 hour. The mixture was then centrifuged at 2500 rpm for 5 minutes. The supernatant was removed and saved for electrochemiluminescence analysis. 1 ml of PBS containing 3% BSA was then added to the beads. The mixture was centrifuged again to separate the beads. This washing and centrifugation process was repeated once more, and afterwards the beads were stored in PBS with 3% BSA. Examples 11-14
The procedure described in Example 10 above was repeated using the particulate magnetic solid phase supports described for Examples 2-9 of Table I.
The result shown in Table I show that particle geometry and transmission properties for polystyrene containing Fe2O3 and soda lime glass provided significantly better and
unexpected results when compared to other materials.
Although the invention has been described in conjunction with specific
embodiments, it is evident that many
alternatives and variations will be apparent to those skilled in the art in light of the foregoing disclosure. Accordingly, the
invention is intended to embrace all of the alternatives and variations that fall with the spirit and scope of the appended claims.
Claims
1. A method of detecting an analyte
comprising:
a) providing a particulate solid phase support with a ligand containing luminescent metal label, said support and luminescent metal label having matched transmissive and emissive properties to enhance the emission from said metal label upon reaction with a coreactant;
b) contacting the solid phase support of step a) with an analyte of interest to form a luminescent labelled solid phase-analyte complex;
c) collecting said complex on an
electrode; and
d) exposing said complex to
electrochemical energy in the presence of a coreactant and measuring the resulting luminescence.
2. The method according to claim 1, wherein said electrogenerated chemiluminescence arises from a reaction of said label and said
coreactant.
3. The method according to claim 1, wherein said coreactant is an amine.
4. The method according to claim 1, wherein said amine is tripropyl amine.
5. The method according to claim 1, wherein said ligand is an antibody, antigen or DNA probe.
6. The method according to claim 1, wherein said particulate solid phase support is selected from magnetic glass and magnetic polystyrene and is contoured to provide reproducible
presentation of said magnetic particulate support to an electrode surface.
7. The method according to claim 6, wherein said ligand is an antibody, antigen or DNA probe.
8. The method according to claim 8, wherein said metal luminescent label is an aromatic, heterocyclic nitrogen-compound containing ruthenium or osmium compound.
9. The method according to claim 4 , wherein said metal luminescent label is formed from 4-methyl-4-N-succinimdyloxy-carbonylpropyl-2,2-bypyridine Ru(II).
10. An electrogenerated chemiluminescent solid phase support comprising:
a particulate substrate providing a
reproducible surface presentation to an
electrode surface and having an exterior layer of a metal luminescent label, said substrate and metal label having matched transmissive and emissive properties to enhance the emission from said metal luminescent label upon reaction with a coreactant.
11. The support to claim 10, wherein said metal label is attached to a ligand is an antibody, antigen or DNA probe.
12. The support according to claim 11, wherein said particulate substrate is selected from magnetic glass and magnetic polystyrene and is contoured to provide reproducible presentation of said magnetic particulate substrate to an electrode surface.
13. The support according to claim 10, wherein said ligand is an antibody, antigen or DNA probe.
14. The support according to claim 10, wherein said luminescent label is succinimdyloxy
carbonylpropyl-2,2-bypyridine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU47562/96A AU4756296A (en) | 1995-01-06 | 1996-01-11 | Electrogenerated chemiluminescence through enhanced particle luminescence |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36923395A | 1995-01-06 | 1995-01-06 | |
US08/369,233 | 1995-01-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996021154A1 true WO1996021154A1 (en) | 1996-07-11 |
Family
ID=23454659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/000493 WO1996021154A1 (en) | 1995-01-06 | 1996-01-11 | Electrogenerated chemiluminescence through enhanced particle luminescence |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4756296A (en) |
WO (1) | WO1996021154A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001006227A3 (en) * | 1999-07-15 | 2001-07-19 | Presens Prec Sensing Gmbh | Production and use of luminescent microparticles and nanoparticles |
EP1042508A4 (en) * | 1997-12-23 | 2002-05-29 | Meso Scale Technologies Llc | Methods and apparatus for improved luminescence assays using microparticles |
WO2006083305A2 (en) | 2004-06-23 | 2006-08-10 | University Of Texas System | Methods and compositions for the detection of biological molecules using a two particle complex |
CN102565381A (en) * | 2010-12-08 | 2012-07-11 | 中国科学院生态环境研究中心 | Immunoassay method by using conductive microparticle-mediated electrochemical luminescence signals |
US8372652B2 (en) | 2008-05-08 | 2013-02-12 | Board Of Regents Of The University Of Texas System | Luminescent nanostructured materials for use in electrogenerated chemiluminescence |
US8586378B2 (en) | 2008-04-11 | 2013-11-19 | Board Of Regents, The University Of Texas System | Method and apparatus for nanoparticle electrogenerated chemiluminescence amplification |
US9075042B2 (en) | 2012-05-15 | 2015-07-07 | Wellstat Diagnostics, Llc | Diagnostic systems and cartridges |
US9213043B2 (en) | 2012-05-15 | 2015-12-15 | Wellstat Diagnostics, Llc | Clinical diagnostic system including instrument and cartridge |
US9625465B2 (en) | 2012-05-15 | 2017-04-18 | Defined Diagnostics, Llc | Clinical diagnostic systems |
US11927592B2 (en) | 2019-01-03 | 2024-03-12 | Meso Scale Technologies, Llc. | Compositions and methods for carrying out assay measurements |
US12429427B2 (en) | 2021-06-30 | 2025-09-30 | Meso Scale Technologies, Llc. | Compositions and methods for assay measurements |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005301A1 (en) * | 1988-11-03 | 1990-05-17 | Igen, Inc. | Electrochemiluminescent assays |
-
1996
- 1996-01-11 AU AU47562/96A patent/AU4756296A/en not_active Abandoned
- 1996-01-11 WO PCT/US1996/000493 patent/WO1996021154A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005301A1 (en) * | 1988-11-03 | 1990-05-17 | Igen, Inc. | Electrochemiluminescent assays |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6846629B2 (en) | 1995-05-09 | 2005-01-25 | Mesoscale Technologies, Llc. | Methods and apparatus for improved luminescence assays using microparticles |
EP1042508A4 (en) * | 1997-12-23 | 2002-05-29 | Meso Scale Technologies Llc | Methods and apparatus for improved luminescence assays using microparticles |
EP2186910A3 (en) * | 1997-12-23 | 2011-04-06 | Meso Scale Technologies LLC | Methods and compositions for improved luminescence assays using microparticles |
US9448235B2 (en) | 1997-12-23 | 2016-09-20 | Meso Scale Technologies Llc. | Methods and apparatus for improved luminescence assays using microparticles |
US6770220B1 (en) | 1999-07-15 | 2004-08-03 | Presens Precision Sensing Gmbh | Production and use of luminescent microparticles and nanoparticles |
WO2001006227A3 (en) * | 1999-07-15 | 2001-07-19 | Presens Prec Sensing Gmbh | Production and use of luminescent microparticles and nanoparticles |
US8871917B2 (en) | 2004-06-23 | 2014-10-28 | Board Of Regents Of The University Of Texas System | Compositions for the detection of biological molecules using a two particle complex |
WO2006083305A2 (en) | 2004-06-23 | 2006-08-10 | University Of Texas System | Methods and compositions for the detection of biological molecules using a two particle complex |
WO2006083305A3 (en) * | 2004-06-23 | 2007-04-05 | Univ Texas | Methods and compositions for the detection of biological molecules using a two particle complex |
US8188243B2 (en) | 2004-06-23 | 2012-05-29 | Board Of Regents Of The University Of Texas System | Methods and compositions for the detection of biological molecules using a two particle complex |
US9442117B2 (en) | 2004-06-23 | 2016-09-13 | Board Of Regents Of The University Of Texas System | Method for the detection of biological molecules using a two particle complex |
US8586378B2 (en) | 2008-04-11 | 2013-11-19 | Board Of Regents, The University Of Texas System | Method and apparatus for nanoparticle electrogenerated chemiluminescence amplification |
US9086370B2 (en) | 2008-04-11 | 2015-07-21 | Board Of Regents Of The University Of Texas System | Method for nanoparticle electrogenerated chemiluminescence amplification |
US9346997B2 (en) | 2008-05-08 | 2016-05-24 | Board Of Regents Of The University Of Texas System | Luminescent nanostructured materials for use in electrogenerated chemiluminescence |
US8372652B2 (en) | 2008-05-08 | 2013-02-12 | Board Of Regents Of The University Of Texas System | Luminescent nanostructured materials for use in electrogenerated chemiluminescence |
CN102565381A (en) * | 2010-12-08 | 2012-07-11 | 中国科学院生态环境研究中心 | Immunoassay method by using conductive microparticle-mediated electrochemical luminescence signals |
US9075042B2 (en) | 2012-05-15 | 2015-07-07 | Wellstat Diagnostics, Llc | Diagnostic systems and cartridges |
US9081001B2 (en) | 2012-05-15 | 2015-07-14 | Wellstat Diagnostics, Llc | Diagnostic systems and instruments |
US9213043B2 (en) | 2012-05-15 | 2015-12-15 | Wellstat Diagnostics, Llc | Clinical diagnostic system including instrument and cartridge |
US9625465B2 (en) | 2012-05-15 | 2017-04-18 | Defined Diagnostics, Llc | Clinical diagnostic systems |
US11927592B2 (en) | 2019-01-03 | 2024-03-12 | Meso Scale Technologies, Llc. | Compositions and methods for carrying out assay measurements |
US12203937B2 (en) | 2019-01-03 | 2025-01-21 | Meso Scale Technologies, Llc. | Compositions and methods for carrying out assay measurements |
US12429427B2 (en) | 2021-06-30 | 2025-09-30 | Meso Scale Technologies, Llc. | Compositions and methods for assay measurements |
Also Published As
Publication number | Publication date |
---|---|
AU4756296A (en) | 1996-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2112675C (en) | Methods and apparatus for improved luminescence assays using particle concentration and chemiluminescence detection | |
JP3182515B2 (en) | Apparatus for improved luminescence assay | |
EP0580979B1 (en) | Method of detection by inducing electrochemiluminescence | |
US5746974A (en) | Apparatus for improved luminescence assays using particle concentration, electrochemical generation of chemiluminescence and chemiluminescence detection | |
US5798083A (en) | Apparatus for improved luminescence assays using particle concentration and chemiluminescence detection | |
US5779976A (en) | Apparatus for improved luminescence assays | |
JP3128541B2 (en) | Apparatus for luminescence assay based on magnetic microparticles containing multiple magnets | |
US5453356A (en) | Luminescent metal chelate labels and means for detection | |
US5705402A (en) | Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets | |
AU637775B2 (en) | Electrochemiluminescent assays | |
US5731147A (en) | Luminescent metal chelate labels and means for detection | |
US20030008339A1 (en) | Methods and apparatus for improved luminescence assays | |
US5962218A (en) | Methods and apparatus for improved luminescence assays | |
US6881536B1 (en) | Particle based electrochemiluminescent assays | |
US5770459A (en) | Methods and apparatus for improved luminescence assays using particle concentration, electrochemical generation of chemiluminescence detection | |
Namba et al. | Highly sensitive electrochemiluminescence immunoassay using the ruthenium chelate-labeled antibody bound on the magnetic micro beads | |
WO1996021154A1 (en) | Electrogenerated chemiluminescence through enhanced particle luminescence | |
Soini | Biospecific assays with time-resolved fluorescence detection | |
US7462322B2 (en) | Methods and apparatus for improved luminescence assays | |
AU676665C (en) | Methods and apparatus for improved luminescence assays usingparticle concentration and chemiluminescence detection | |
HK1013861B (en) | Method of detection by inducing electrochemiluminescence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |